Prenetics Global Limited

Healthcare

NASDAQ:PRE · NASDAQ Global Market

Market Cap $348.51M Beta 0.24 P/E (TTM) -4.9

$20.50 +2.19%

+$0.43 today

52W Low $7.18High $23.63

Vol 0.14M · Avg 0.22M

EPS (TTM) -$4.18Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+152.15%

Period High

$22.15

Period Low

$7.25

Latest

$20.50

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

OraSure Technologies, Inc.

NASDAQ:OSUR

$297.08M

Armata Pharmaceuticals, Inc.

AMEX:ARMP

$258.63M

Codexis, Inc.

NASDAQ:CDXS

$224.97M

Profound Medical Corp.

NASDAQ:PROF

$206.07M

TriSalus Life Sciences, Inc.

NASDAQ:TLSI

$148.80M

Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

$143.33M

MaxCyte, Inc.

NASDAQ:MXCT

$126.40M

Neuronetics, Inc.

NASDAQ:STIM

$84.55M

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

$72.50M

Atlantic International Corp.

NASDAQ:ATLN

$41.58M

What is the latest PRE filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does PRE have?

Intrinsic Alpha currently shows 20 recent filings for PRE.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.